2026 Memphis Hematologic Malignancies Symposium
Accreditation: 4.50 ABIM MOC II | 4.50 AMA PRA Category 1 Credit™ | 4.50 ACPE Pharmacy | 4.50 Nursing Contact Hours
Venue: Memphis Riverline Hotel, 250 North Main Street, Memphis, TN, United States
Official conference page for 2026 Memphis Hematologic Malignancies Symposium. https://binaytara.org/projects/conferences/memphis-hematologic-malignancies-symposium
About 2026 Memphis Hematologic Malignancies Symposium
Conference program and agenda
Our Agenda
Saturday, August 22nd, 2026
All timings are in Central Time (CDT, GMT-05:00) time.
Session Chair: Jason Chandler, MD
08:30 AM - 08:50 AM
CAR-T vs BiTE Therapy – Carolina Schinke, MD
08:50 AM - 09:10 AM
Whether to transplant or not to transplant – Salil Goorha, MD
09:10 AM - 09:30 AM
Using MRD to stop maintenance? – Abdullah Khan, MBBS
09:30 AM - 10:00 AM
Case based panel discussion – Jason Chandler, MD
Session Chair: Jeff Harris, MD
10:10 AM - 10:30 AM
CLL: Time-limited or Continous? – Alaa Altahan, MD
10:30 AM - 10:50 AM
The evolving treatment landscape in relapsed/refractory DLBCL – Pallawi Torka, MD
10:50 AM - 11:10 AM
Chemo-free Approach to ALL – Emily Curran , MD
11:10 AM - 11:40 AM
Case based panel discussion – Clesheree Stepter, NP
Session Chair: Swapna Thota, MD
11:40 AM - 12:00 PM
Who would you currently induce for AML in 2026? – Stephen Anthony Strickland, MD
12:00 PM - 12:20 PM
Germline Predisposition for Adults – Swapna Thota, MD
12:20 PM - 12:40 PM
Clonal Hematopoiesis and Current Treatment Algorithms – Ashwin Kishtagari, MD
12:40 PM - 01:10 PM
Case based panel discussion – Jonathan Blackmon, MD